The pen needles market is projected to reach USD 3.08 Billion by 2030 from USD 1.81 Billion in 2024 at a CAGR of 9.2% during the forecast period. The elderly are susceptible, due to their age, to insulin resistance, a decrease in pancreatic function, and other comorbid conditions, including hypertension and obesity, which raise the risk of developing diabetes. As people age, the body becomes less responsive to insulin's role in regulating blood sugar, hence increasing the chances of developing Type 2 diabetes. In addition, the reduction in physical activity among older adults, coupled with lifestyle changes, contributes to rising trends of the condition. The increasing incidence rate of diabetes with age has simple direct implications concerning the increased desire for insulin administration devices, especially the pen needles. Insulin injections are an essential component of diabetes management among elderly patients, especially patients with Type 1 or advanced Type 2 diabetes. Ease of use, convenience, and reduced pain compared to traditional syringes make the pen needle particularly suitable for older adults. Other conditions most of the elderly suffer from include arthritis, which could primarily hinder them using syringes, hence developing the preference for insulin pens that use pen needles.
“The standard pen needles segment is accounted for the largest share of global pen needles market.”
The market share of pen needles in the global market is dominated by the standard ones because of their wide compatibility with most of the pen injectors used for insulin administration and other injectable drugs. These needles are developed to be able to fit in a variety of insulin pens, making them available to patients across all demographics.Their simplicity and affordability make them popular, and their ease of use is something that is found in regions whose populations are rather cost-sensitive. Standard pen needles are also apt for Type 1 and Type 2 diabetes patients. Other patients also require injectable medications for some other conditions; hence, standard pen needles find wide usage in all these conditions, making the patients and their healthcare providers retain them as a first choice for their use.
“Online purchase segment will grow at the highest CAGR during the forecast period of the global pen needles market.”
The online purchase segment of the global pen needles market is expected to have the highest growth rate during the forecast period due to the benefits and convenience that e-commerce platforms have provided. For instance, the websites provide competitive prices and, sometimes, offer discounts, promotional offers, and bundle deals that can make the purchase of pen needles cheaper for customers. Apart from this, the appeal of online shopping is greater than traditional retail shops due to more ease in product comparison, reading customer reviews, and availability of a comprehensive range of products and sizes. The availability on online platforms also increases the accessibility for customers located at remote locations or those with some mobility issues since they can receive their pen needles at home. E-commerce adoption, with more convenience and cost-effectiveness, ensures that the segment of online purchases is going to grow strongly.
“North America to witness the substantial growth rate during the forecast period.”
The pen needles market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa and GCC Countries based on the region type. In 2024, the Asia Pacific region is projected to exhibit the highest CAGR during the forecast period. However, North America accounts for the largest market share of the pen needles market in 2024. This is largely because of the health care systems that are advanced to facilitate better access to diabetes care. The U.S. and Canada have a well-developed medical infrastructure, making it easy for patients to reach pen needles for insulin delivery devices. Furthermore, with millions of people suffering from diabetes in these regions, there is high demand for effective, as well as user-friendly, delivery solutions. Pen needles are popular for their convenience, ease of use, and minimal discomfort. It is the preferred way to manage Type 1 and Type 2 diabetes. With extensive healthcare coverage, a high patient awareness level, and a large diabetic population, North America is the most significant market for pen needles.
A breakdown of the primary participants (supply-side) for the pen needles market referred to for this report is provided below:
• By Company Type: Tier 1–22%, Tier 2–36%, and Tier 3–42%
• By Designation: C-level–23%, Director Level–28%, and Others–49%
• By Region: North America–38%, Europe–29%, Asia Pacific–23%, Latin America- 6%, and Middle East and Africa– 1% and GCC Countries– 3%
Prominent players in this market include Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B. Braun SE (Germany), Owen Mumford (UK), Terumo Corporation (Japan), NIPRO Corporation (Japan), Allison Medical, Inc. (US), AdvaCare Pharma (US), Berpu Medical Technology Co., Ltd. (China), ARKRAY, Inc. (Japan), GlucoRx Limited (UK), HTL-STREFA (Poland), UltiMed, Inc. (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Medical Devices Inc. (Canada), Montmed, Inc. (Canada), Trividia Health, Inc. (US), VOGT Medical Vertrieb GmbH (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), IYON Medical (Turkey), Links Medical Products, Inc. (US), and MHC Medical Products, LLC (US).
Research Coverage:
The market study covers the pen needles market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, length, application, mode of purchase, setting and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
Analysis of Market Dynamics: Drivers (rising incidence of chronic diseases, favorable reimbursements in certain countries, and decreasing prices of insulin formulations) restraints (rising pet care costs, poor reimbursement scenario in emerging countries, and needle anxiety) opportunities (growing preference for biosimilar drugs, emerging economies to offer high-growth potential, and rising healthcare expenditure on diabetes), and challenges (implementation of regulations for safety pen needles, reuse of pen needles, and misuse of injection pens)
Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the pen needles market.
Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, end-user, and region.
Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the pen needles market.
Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the pen needles market like Embecta Corp. (US), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), B. Braun SE (Germany), and Terumo Corporation (Japan).
圖表清單 List of Tables & Figures
TABLE 1 STANDARD CURRENCY CONVERSION RATES 27
TABLE 2 PEN NEEDLES MARKET: STUDY ASSUMPTIONS 43
TABLE 3 PEN NEEDLES MARKET: RISK ASSESSMENT ANALYSIS 44
TABLE 4 REIMBURSEMENT OF PEN NEEDLES, BY COUNTRY 61
TABLE 5 INDICATIVE SELLING PRICE OF PEN NEEDLES, BY KEY PLAYER, 2024 62
TABLE 6 PEN NEEDLES MARKET: ROLE IN ECOSYSTEM 66
TABLE 7 PEN NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS 67
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73
TABLE 11 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION 75
TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 75
TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 76
TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 78
TABLE 16 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL 78
TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 79
TABLE 18 TRADE ANALYSIS OF NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES, 2023 (USD MILLION) 80
TABLE 19 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839), BY COUNTRY, 2019–2023 (USD THOUSAND) 80
TABLE 20 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES (HS CODE 901839), BY COUNTRY, 2019–2023 (USD THOUSAND) 81
TABLE 21 PEN INJECTORS MARKET: MAJOR PATENTS 84
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PEN NEEDLES 86
TABLE 23 KEY BUYING CRITERIA FOR PEN NEEDLES 86
TABLE 24 IMPACT OF CCG-WIDE INSULIN PEN NEEDLE 87
TABLE 25 PEN NEEDLE DESIGN INFLUENCES EASE OF INSERTION, PAIN, AND SKIN
TRAUMA IN SUBJECTS WITH TYPE 2 DIABETES 88
TABLE 26 DROPSAFE SAFETY PEN NEEDLE HELPS TO PREVENT ACCIDENTAL NEEDLESTICKS AFTER INJECTIONS 89
TABLE 27 PEN NEEDLES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
(2025–2026) 92
TABLE 28 PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 103
TABLE 29 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS 104
TABLE 30 STANDARD PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 105
TABLE 31 STANDARD PEN NEEDLES MARKET, BY REGION, 2022–2030 (MILLION UNITS) 105
TABLE 32 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS 106
TABLE 33 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 107
TABLE 34 SAFETY PEN NEEDLES MARKET, BY REGION, 2022–2030 (MILLION UNITS) 107
TABLE 35 PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 109
TABLE 36 8MM PEN NEEDLES OFFERED BY KEY PLAYERS 110
TABLE 37 8MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111
TABLE 38 5MM PEN NEEDLES OFFERED BY KEY PLAYERS 112
TABLE 39 5MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 113
TABLE 40 6MM PEN NEEDLES OFFERED BY KEY PLAYERS 114
TABLE 41 6MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 115
TABLE 42 4MM PEN NEEDLES OFFERED BY KEY PLAYERS 116
TABLE 43 4MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 117
TABLE 44 12MM PEN NEEDLES OFFERED BY KEY PLAYERS 118
TABLE 45 12MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 119
TABLE 46 10MM PEN NEEDLES OFFERED BY KEY PLAYERS 120
TABLE 47 10MM PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 121
TABLE 48 PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 123
TABLE 49 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY,
2022–2030 (USD MILLION) 124
TABLE 50 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY,
2022–2030 (USD MILLION) 126
TABLE 51 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY,
2022–2030 (USD MILLION) 127
TABLE 52 PEN NEEDLES MARKET FOR OSTEOPOROSIS, BY COUNTRY,
2022–2030 (USD MILLION) 128
TABLE 53 PEN NEEDLES MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2022–2030 (USD MILLION) 130
TABLE 54 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION) 132
TABLE 55 PEN NEEDLES MARKET FOR PRESCRIPTION-BASED PURCHASES, BY COUNTRY, 2022–2030 (USD MILLION) 133
TABLE 56 PEN NEEDLES MARKET FOR OTC PURCHASES, BY COUNTRY,
2022–2030 (USD MILLION) 134
TABLE 57 PEN NEEDLES MARKET FOR ONLINE PURCHASES, BY COUNTRY,
2022–2030 (USD MILLION) 135
TABLE 58 PEN NEEDLES MARKET FOR OTHER MODES OF PURCHASE, BY COUNTRY,
2022–2030 (USD MILLION) 137
TABLE 59 PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 139
TABLE 60 PEN NEEDLES MARKET FOR HOME CARE SETTINGS, BY COUNTRY,
2022–2030 (USD MILLION) 140
TABLE 61 PEN NEEDLES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2022–2030 (USD MILLION) 141
TABLE 62 PEN NEEDLES MARKET FOR OTHER CARE SETTINGS, BY COUNTRY,
2022–2030 (USD MILLION) 142
TABLE 63 PEN NEEDLES MARKET, BY REGION, 2022–2030 (USD MILLION) 144
TABLE 64 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 146
TABLE 65 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 146
TABLE 66 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH,
2022–2030 (USD MILLION) 146
TABLE 67 NORTH AMERICA: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 147
TABLE 68 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 147
TABLE 69 NORTH AMERICA: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 147
TABLE 70 MACROECONOMIC INDICATORS FOR US 149
TABLE 71 US: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 149
TABLE 72 US: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 150
TABLE 73 US: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 150
TABLE 74 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION) 150
TABLE 75 US: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 151
TABLE 76 MACROECONOMIC INDICATORS FOR CANADA 152
TABLE 77 CANADA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 152
TABLE 78 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 153
TABLE 79 CANADA: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 153
TABLE 80 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 153
TABLE 81 CANADA: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 154
TABLE 82 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 155
TABLE 83 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 155
TABLE 84 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 156
TABLE 85 EUROPE: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 156
TABLE 86 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 156
TABLE 87 EUROPE: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 157
TABLE 88 MACROECONOMIC INDICATORS FOR GERMANY 158
TABLE 89 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 158
TABLE 90 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 159
TABLE 91 GERMANY: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 159
TABLE 92 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 159
TABLE 93 GERMANY: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 160
TABLE 94 MACROECONOMIC INDICATORS FOR UK 161
TABLE 95 UK: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 161
TABLE 96 UK: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 162
TABLE 97 UK: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 162
TABLE 98 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION) 162
TABLE 99 UK: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 163
TABLE 100 MACROECONOMIC INDICATORS FOR FRANCE 163
TABLE 101 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 164
TABLE 102 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 164
TABLE 103 FRANCE: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 165
TABLE 104 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 165
TABLE 105 FRANCE: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 165
TABLE 106 MACROECONOMIC INDICATORS FOR ITALY 166
TABLE 107 ITALY: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 167
TABLE 108 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 167
TABLE 109 ITALY: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 167
TABLE 110 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 168
TABLE 111 ITALY: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 168
TABLE 112 MACROECONOMIC INDICATORS FOR SPAIN 169
TABLE 113 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 169
TABLE 114 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 170
TABLE 115 SPAIN: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 170
TABLE 116 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 170
TABLE 117 SPAIN: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 171
TABLE 118 REST OF EUROPE: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 171
TABLE 119 REST OF EUROPE: PEN NEEDLES MARKET, BY LENGTH,
2022–2030 (USD MILLION) 172
TABLE 120 REST OF EUROPE: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 172
TABLE 121 REST OF EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 172
TABLE 122 REST OF EUROPE: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 173
TABLE 123 ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 176
TABLE 124 ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 176
TABLE 125 ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 176
TABLE 126 ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 177
TABLE 127 ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 177
TABLE 128 ASIA PACIFIC: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 177
TABLE 129 MACROECONOMIC INDICATORS FOR JAPAN 178
TABLE 130 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 179
TABLE 131 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 179
TABLE 132 JAPAN: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 179
TABLE 133 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 180
TABLE 134 JAPAN: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 180
TABLE 135 MACROECONOMIC INDICATORS FOR CHINA 181
TABLE 136 CHINA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 181
TABLE 137 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 182
TABLE 138 CHINA: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 182
TABLE 139 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 182
TABLE 140 CHINA: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 183
TABLE 141 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE,
2022–2030 (USD MILLION) 183
TABLE 142 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH,
2022–2030 (USD MILLION) 184
TABLE 143 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 184
TABLE 144 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2022–2030 (USD MILLION) 184
TABLE 145 AUSTRALIA & NEW ZEALAND: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 185
TABLE 146 MACROECONOMIC INDICATORS FOR INDIA 185
TABLE 147 INDIA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 186
TABLE 148 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 186
TABLE 149 INDIA: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 186
TABLE 150 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 187
TABLE 151 INDIA: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 187
TABLE 152 MACROECONOMIC INDICATORS FOR SOUTH KOREA 188
TABLE 153 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 188
TABLE 154 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 189
TABLE 155 SOUTH KOREA: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 189
TABLE 156 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 189
TABLE 157 SOUTH KOREA: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 190
TABLE 158 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 191
TABLE 159 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH,
2022–2030 (USD MILLION) 192
TABLE 160 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 192
TABLE 161 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 192
TABLE 162 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 193
TABLE 163 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE,
2022–2030 (USD MILLION) 193
TABLE 164 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY LENGTH,
2022–2030 (USD MILLION) 193
TABLE 165 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 194
TABLE 166 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 194
TABLE 167 REST OF ASIA PACIFIC: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 194
TABLE 168 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 195
TABLE 169 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 196
TABLE 170 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 196
TABLE 171 LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 196
TABLE 172 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 197
TABLE 173 LATIN AMERICA: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 197
TABLE 174 MACROECONOMIC INDICATORS FOR BRAZIL 198
TABLE 175 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 198
TABLE 176 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 199
TABLE 177 BRAZIL: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 199
TABLE 178 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 199
TABLE 179 BRAZIL: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 200
TABLE 180 MACROECONOMIC INDICATORS FOR MEXICO 200
TABLE 181 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 201
TABLE 182 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 201
TABLE 183 MEXICO: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 201
TABLE 184 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 202
TABLE 185 MEXICO: PEN NEEDLES MARKET, BY CARE SETTING, 2022–2030 (USD MILLION) 202
TABLE 186 MACROECONOMIC INDICATORS FOR ARGENTINA 203
TABLE 187 ARGENTINA: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 203
TABLE 188 ARGENTINA: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 204
TABLE 189 ARGENTINA: PEN NEEDLES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 204
TABLE 190 ARGENTINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 204
TABLE 191 ARGENTINA: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 205
TABLE 192 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE,
2022–2030 (USD MILLION) 205
TABLE 193 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH,
2022–2030 (USD MILLION) 206
TABLE 194 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 206
TABLE 195 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 206
TABLE 196 REST OF LATIN AMERICA: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 207
TABLE 197 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE,
2022–2030 (USD MILLION) 208
TABLE 198 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY LENGTH,
2022–2030 (USD MILLION) 208
TABLE 199 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 208
TABLE 200 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 209
TABLE 201 MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 209
TABLE 202 GCC COUNTRIES: PEN NEEDLES MARKET, BY TYPE, 2022–2030 (USD MILLION) 210
TABLE 203 GCC COUNTRIES: PEN NEEDLES MARKET, BY LENGTH, 2022–2030 (USD MILLION) 211
TABLE 204 GCC COUNTRIES: PEN NEEDLES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 211
TABLE 205 GCC COUNTRIES: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2022–2030 (USD MILLION) 211
TABLE 206 GCC COUNTRIES: PEN NEEDLES MARKET, BY CARE SETTING,
2022–2030 (USD MILLION) 212
TABLE 207 PEN NEEDLES MARKET: DEGREE OF COMPETITION 216
TABLE 208 PEN NEEDLES MARKET: REGION FOOTPRINT 220
TABLE 209 PEN NEEDLES MARKET: TYPE FOOTPRINT 221
TABLE 210 PEN NEEDLES MARKET: LENGTH FOOTPRINT 222
TABLE 211 PEN NEEDLES MARKET: APPLICATION FOOTPRINT 223
TABLE 212 PEN NEEDLES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 226
TABLE 213 PEN NEEDLES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 227
TABLE 214 PEN NEEDLES MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021- JANUARY 2025 229
TABLE 215 PEN NEEDLES MARKET: DEALS, JANUARY 2021– JANUARY 2025 229
TABLE 216 PEN NEEDLES MARKET: EXPANSIONS, JANUARY 2021– JANUARY 2025 230
TABLE 217 EMBECTA CORP.: COMPANY OVERVIEW 233
TABLE 218 EMBECTA CORP.: PRODUCTS OFFERED 234
TABLE 219 EMBECTA CORP.: DEALS, JANUARY 2021–JANUARY 2025 235
TABLE 220 EMBECTA CORP.: EXPANSIONS, JANUARY 2021–JANUARY 2025 235
TABLE 221 EMBECTA CORP.: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025 236
TABLE 222 NOVO NORDISK A/S: COMPANY OVERVIEW 237
TABLE 223 NOVO NORDISK A/S: PRODUCTS OFFERED 238
TABLE 224 NOVO NORDISK A/S: EXPANSIONS, JANUARY 2021–JANUARY 2025 239
TABLE 225 B. BRAUN SE: COMPANY OVERVIEW 240
TABLE 226 B. BRAUN SE: PRODUCTS OFFERED 241
TABLE 227 YPSOMED: COMPANY OVERVIEW 243
TABLE 228 YPSOMED: PRODUCTS OFFERED 245
TABLE 229 YPSOMED: DEALS, JANUARY 2021–JANUARY 2025 245
TABLE 230 TERUMO CORPORATION: COMPANY OVERVIEW 247
TABLE 231 TERUMO CORPORATION: PRODUCTS OFFERED 248
TABLE 232 NIPRO: COMPANY OVERVIEW 250
TABLE 233 NIPRO: PRODUCTS OFFERED 251
TABLE 234 NIPRO: EXPANSIONS, JANUARY 2021–JANUARY 2025 252
TABLE 235 OWEN MUMFORD: COMPANY OVERVIEW 254
TABLE 236 OWEN MUMFORD: PRODUCTS OFFERED 254
TABLE 237 OWEN MUMFORD: DEALS, JANUARY 2021–JANUARY 2025 255
TABLE 238 ARKRAY, INC.: COMPANY OVERVIEW 256
TABLE 239 ARKRAY, INC.: PRODUCTS OFFERED 256
TABLE 240 ARKRAY, INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025 257
TABLE 241 ULTIMED, INC.: COMPANY OVERVIEW 258
TABLE 242 ULTIMED, INC.: PRODUCTS OFFERED 258
TABLE 243 ULTIMED, INC.: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 259
TABLE 244 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: COMPANY OVERVIEW 260
TABLE 245 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: PRODUCTS OFFERED 260
TABLE 246 MONTMÉD: COMPANY OVERVIEW 261
TABLE 247 MONTMÉD: PRODUCTS OFFERED 261
TABLE 248 MONTMÉD: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025 261
TABLE 249 MONTMÉD: DEALS, JANUARY 2021–JANUARY 2025 262
TABLE 250 HTL-STREFA: COMPANY OVERVIEW 263
TABLE 251 HTL-STREFA: PRODUCTS OFFERED 263
TABLE 252 ALLISON MEDICAL, INC.: COMPANY OVERVIEW 265
TABLE 253 ALLISON MEDICAL, INC.: PRODUCTS OFFERED 265
TABLE 254 GLUCORX LIMITED: COMPANY OVERVIEW 266
TABLE 255 GLUCORX LIMITED: PRODUCTS OFFERED 266
TABLE 256 BERPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 267
TABLE 257 BERPU MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 267
TABLE 258 VAN HEEK MEDICAL: COMPANY OVERVIEW 268
TABLE 259 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW 269
TABLE 260 IYON HEALTH MEDICAL: COMPANY OVERVIEW 270
TABLE 261 LINKS MEDICAL PRODUCTS INC.: COMPANY OVERVIEW 271
TABLE 262 MHC MEDICAL PRODUCTS, LLC: COMPANY OVERVIEW 271
TABLE 263 ADVACARE PHARMA: COMPANY OVERVIEW 272
TABLE 264 ARTSANA S.P.A.: COMPANY OVERVIEW 273
TABLE 265 PROMISEMED MEDICAL DEVICES, INC.: COMPANY OVERVIEW 274
TABLE 266 TRIVIDIA HEALTH, INC.: COMPANY OVERVIEW 275
TABLE 267 VOGT MEDICAL VERTRIEB GMBH: COMPANY OVERVIEW 276
_
_
FIGURE 1 MARKETS & REGIONS COVERED 26
FIGURE 2 RESEARCH DESIGN 30
FIGURE 3 PRIMARY SOURCES 32
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 34
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE):
BY CARE SETTING AND REGION 35
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 36
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: EMBECTA CORP. (2023) 37
FIGURE 9 PEN NEEDLES MARKET: REVENUE ANALYSIS OF TOP FIVE COMPANIES (2023) 37
FIGURE 10 DEMAND-SIDE ANALYSIS 38
FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2030) 40
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 40
FIGURE 13 TOP-DOWN APPROACH 41
FIGURE 14 DATA TRIANGULATION METHODOLOGY 42
FIGURE 15 PEN NEEDLES MARKET, BY TYPE, 2024 VS. 2030 (USD MILLION) 45
FIGURE 16 PEN NEEDLES MARKET, BY LENGTH, 2024 VS. 2030 (USD MILLION) 46
FIGURE 17 PEN NEEDLES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 46
FIGURE 18 PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2024 VS. 2030 (USD MILLION) 47
FIGURE 19 PEN NEEDLES MARKET, BY CARE SETTING, 2024 VS. 2030 (USD MILLION) 47
FIGURE 20 GEOGRAPHIC GROWTH OPPORTUNITIES 48
FIGURE 21 RISING INCIDENCE OF DIABETES TO PROPEL MARKET 49
FIGURE 22 8MM SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN
ASIA PACIFIC IN 2024 50
FIGURE 23 EMERGING MARKETS TO GROW AT HIGHER CAGRS DURING FORECAST PERIOD 51
FIGURE 24 NORTH AMERICA DOMINATED MARKET IN 2024 51
FIGURE 25 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
FIGURE 26 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN US,
1995–2030 (MILLION INDIVIDUALS) 53
FIGURE 27 TYPE 1 DIABETIC POPULATION, BY COUNTRY (2022) 54
FIGURE 28 AVERAGE SELLING PRICE TREND OF STANDARD PEN NEEDLES, BY REGION, 2022–2024 (USD) 64
FIGURE 29 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS 65
FIGURE 30 PEN NEEDLES MARKET: ECOSYSTEM ANALYSIS 66
FIGURE 31 PEN NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS 68
FIGURE 32 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS 71
FIGURE 33 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS 76
FIGURE 34 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES 77
FIGURE 35 PATENT PUBLICATION TRENDS (JANUARY 2014–DECEMBER 2024) 82
FIGURE 36 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR
PEN NEEDLE PATENTS (JANUARY 2014–DECEMBER 2024) 83
FIGURE 37 TOP APPLICANT COUNTRIES FOR PEN NEEDLE PATENTS
(JANUARY 2013–DECEMBER 2024) 84
FIGURE 38 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
PEN NEEDLES 85
FIGURE 39 KEY BUYING CRITERIA FOR PEN NEEDLES, BY TYPE 86
FIGURE 40 AUTOINJECTORS MARKET OVERVIEW 94
FIGURE 41 INSULIN DELIVERY DEVICES MARKET OVERVIEW 95
FIGURE 42 INJECTION PENS MARKET OVERVIEW 96
FIGURE 43 NEEDLES MARKET OVERVIEW 97
FIGURE 44 IMPACT OF AI/GEN AI ON PEN NEEDLES MARKET 98
FIGURE 45 PEN NEEDLES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 99
FIGURE 46 FUNDING AND NUMBER OF DEALS IN PEN NEEDLES MARKET,
2018–2022 (USD MILLION) 100
FIGURE 47 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 101
FIGURE 48 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION) 101
FIGURE 49 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT 145
FIGURE 50 TOTAL FERTILITY RATE IN US POPULATION, 1990−2024 148
FIGURE 51 ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT 175
FIGURE 52 PREVALENCE OF DIABETES IN SOUTHEAST ASIA, 2021 VS. 2030 190
FIGURE 53 HEALTHCARE EXPENDITURE IN SOUTHEAST ASIA, 2021 (% GDP) 191
FIGURE 54 ELDERLY POPULATION IN SOUTHEAST ASIA, 2022 191
FIGURE 55 HEALTH EXPENDITURE IN LATIN AMERICA FOR 2021 (% GDP) 205
FIGURE 56 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PEN NEEDLES MARKET 214
FIGURE 57 REVENUE ANALYSIS FOR KEY PLAYERS IN PEN NEEDLES MARKET (2019–2023) 215
FIGURE 58 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PEN NEEDLES MARKET (2023) 216
FIGURE 59 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 218
FIGURE 60 PEN NEEDLES MARKET: COMPANY FOOTPRINT 219
FIGURE 61 PEN NEEDLES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 225
FIGURE 62 EV/EBITDA OF KEY VENDORS 227
FIGURE 63 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 228
FIGURE 64 PEN NEEDLES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 231
FIGURE 65 PEN NEEDLES MARKET: R&D EXPENDITURE OF KEY PLAYERS (2022 VS. 2023) 232
FIGURE 66 EMBECTA CORP.: COMPANY SNAPSHOT 234
FIGURE 67 NOVO NORDISK A/S: COMPANY SNAPSHOT 238
FIGURE 68 B. BRAUN SE: COMPANY SNAPSHOT 241
FIGURE 69 YPSOMED: COMPANY SNAPSHOT 244
FIGURE 70 TERUMO CORPORATION: COMPANY SNAPSHOT 248
FIGURE 71 NIPRO: COMPANY SNAPSHOT 251